ARTURO MARCHAND, M.D.
4275 BURNHAM AVE SUITE #100, LAS VEGAS, NV 89119
NPI Number
1811077670
Practice location · View on Google Maps
Total Medicaid Payments
$99,902
-73% vs specialty average
Patients Seen
996
Total Claims
1,029
$ Per Patient
$100
Specialty avg: $35
Specialty Rank
#20 of 93
Internal Medicine, Cardiovascular Disease providers in Nevada
Peer Average
$369,495
Average total for Internal Medicine, Cardiovascular Disease
Claims per Patient
1.0
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2018 | $99,902 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| 99214 | Office visit for a moderate problem (established patient) | 313 | $33,666 | 33.7% | $108 |
| 78452 | Nuclear medicine imaging (using small amounts of radioactive material) | 43 | $22,630 | 22.7% | $526 |
| 93306 | Heart ultrasound (echocardiogram) | 93 | $15,135 | 15.2% | $163 |
| 99204 | New patient office visit — detailed visit for a serious problem | 72 | $11,975 | 12.0% | $166 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 43 | $8,406 | 8.4% | $195 |
| 93015 | Heart monitoring test (ECG/EKG) | 43 | $2,968 | 3.0% | $69 |
| 93000 | Heart monitoring test (ECG/EKG) | 162 | $2,422 | 2.4% | $15 |
| 93010 | Heart monitoring test (ECG/EKG) | 245 | $1,751 | 1.8% | $7 |
| 99213 | Office visit for a simple problem (established patient) | 15 | $949 | 1.0% | $63 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.